97 related articles for article (PubMed ID: 26564513)
21. Prognostic value of change in anti-thyroglobulin antibodies after thyroidectomy in patients with papillary thyroid carcinoma.
Ernaga-Lorea A; Hernández-Morhain MC; Anda-Apiñániz E; Pineda-Arribas JJ; Migueliz-Bermejo I; Eguílaz-Esparza N; Irigaray-Echarri A
Clin Transl Oncol; 2018 Jun; 20(6):740-744. PubMed ID: 29071517
[TBL] [Abstract][Full Text] [Related]
22. Utility of 8F-FDG PET/CT in well differentiated thyroid carcinoma with high serum antithyroglobulin antibody.
Kingpetch K; Pipatrattana R; Tepmongkol S; Sirisalipoch S; Chaiwatanarat T
J Med Assoc Thai; 2011 Oct; 94(10):1238-44. PubMed ID: 22145510
[TBL] [Abstract][Full Text] [Related]
23. Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using (18)F-FDG PET/CT.
Seo JH; Lee SW; Ahn BC; Lee J
Clin Endocrinol (Oxf); 2010 Apr; 72(4):558-63. PubMed ID: 19744107
[TBL] [Abstract][Full Text] [Related]
24. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.
Spencer CA; Takeuchi M; Kazarosyan M; Wang CC; Guttler RB; Singer PA; Fatemi S; LoPresti JS; Nicoloff JT
J Clin Endocrinol Metab; 1998 Apr; 83(4):1121-7. PubMed ID: 9543128
[TBL] [Abstract][Full Text] [Related]
25. Sequential changes of serum antithyroglobulin antibody levels are a good predictor of disease activity in thyroglobulin-negative patients with papillary thyroid carcinoma.
Hsieh CJ; Wang PW
Thyroid; 2014 Mar; 24(3):488-93. PubMed ID: 23971786
[TBL] [Abstract][Full Text] [Related]
26. [Influence of endogenous TgAb upon serum Tg measurement results and Tg positive rate in patients with differentiated thyroid carcinoma].
Zhang W; Deng H; Pan M; Huang R; Tang G
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Aug; 30(4):803-7. PubMed ID: 24059060
[TBL] [Abstract][Full Text] [Related]
27. Can preoperative thyroglobulin antibody levels be used as a marker for well differentiated thyroid cancer?
Hosseini S; Payne RJ; Zawawi F; Mlynarek A; Hier MP; Tamilia M; Forest VI
J Otolaryngol Head Neck Surg; 2016 May; 45(1):31. PubMed ID: 27179632
[TBL] [Abstract][Full Text] [Related]
28. Correlation of 18F-FDG PET/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I whole-body scan results.
Ozkan E; Aras G; Kucuk NO
Clin Nucl Med; 2013 May; 38(5):326-31. PubMed ID: 23486319
[TBL] [Abstract][Full Text] [Related]
29. The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies.
Boi F; Baghino G; Atzeni F; Lai ML; Faa G; Mariotti S
J Clin Endocrinol Metab; 2006 Apr; 91(4):1364-9. PubMed ID: 16434461
[TBL] [Abstract][Full Text] [Related]
30. Serial Thyroglobulin Variation Trend Shortly after Radioiodine Therapy in Poorly to Moderately Differentiated Recurrent Thyroid Cancer.
Li CX; Hou M; Ren C; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Jun; 38(3):351-5. PubMed ID: 27469925
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Antithyroglobulin Antibody Concentrations Before and After Ablation with 131I as a Predictor of Structural Disease in Differentiated Thyroid Carcinoma Patients with Undetectable Basal Thyroglobulin and Negative Neck Ultrasonography.
Rosario PW; Carvalho M; Mourão GF; Calsolari MR
Thyroid; 2016 Apr; 26(4):525-31. PubMed ID: 26831821
[TBL] [Abstract][Full Text] [Related]
32. The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation.
Phan HT; Jager PL; van der Wal JE; Sluiter WJ; Plukker JT; Dierckx RA; Wolffenbuttel BH; Links TP
Eur J Endocrinol; 2008 Jan; 158(1):77-83. PubMed ID: 18166820
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of the combined antithyroglobulin antibodies and thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer.
Rubello D; Girelli ME; Casara D; Piccolo M; Perin A; Busnardo B
J Endocrinol Invest; 1990 Oct; 13(9):737-42. PubMed ID: 2292657
[TBL] [Abstract][Full Text] [Related]
34. Incidence and implications of negative serum thyroglobulin but positive I-131 whole-body scans in patients with well-differentiated thyroid cancer prepared with rhTSH or thyroid hormone withdrawal.
Cherk MH; Francis P; Topliss DJ; Bailey M; Kalff V
Clin Endocrinol (Oxf); 2012 May; 76(5):734-40. PubMed ID: 22050475
[TBL] [Abstract][Full Text] [Related]
35. Clinical laboratory verification of thyroglobulin concentrations in the presence of autoantibodies to thyroglobulin: comparison of EIA, radioimmunoassay and LC MS/MS measurements in an Urban Hospital.
Wheeler SE; Liu L; Blair HC; Sivak R; Longo N; Tischler J; Mulvey K; Palmer OMP
BMC Res Notes; 2017 Dec; 10(1):725. PubMed ID: 29221487
[TBL] [Abstract][Full Text] [Related]
36. Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma.
Kim WG; Yoon JH; Kim WB; Kim TY; Kim EY; Kim JM; Ryu JS; Gong G; Hong SJ; Shong YK
J Clin Endocrinol Metab; 2008 Dec; 93(12):4683-9. PubMed ID: 18812478
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the BRAHMS Kryptor(®) thyroglobulin minirecovery test in patients with differentiated thyroid carcinoma.
Giovanella L; Imperiali M; Verburg FA; Ceriani L
Clin Chem Lab Med; 2013 Feb; 51(2):449-53. PubMed ID: 23095203
[TBL] [Abstract][Full Text] [Related]
38. [Positive antithyroglobulin antibodies in patients with differentiated thyroid carcinoma. What significance?].
Larbre H; Schvartz C; Schneider N; Delcourt AC; Maes B; Pochart JM; Vaudrey C
Ann Endocrinol (Paris); 2000 Nov; 61(5):422-7. PubMed ID: 11084393
[TBL] [Abstract][Full Text] [Related]
39. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
[TBL] [Abstract][Full Text] [Related]
40. Persistent or Recurrent Disease in Thyroid Cancer Survivors Who Have Elevated Serum Antithyroglobulin Antibodies.
Robbins RJ; Cubb TD; Zahid M; Xu J
Endocr Pract; 2023 Jun; 29(6):436-440. PubMed ID: 36889583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]